Economic evaluations of clinical pharmacy services: 2006-2010

Pharmacotherapy

Volumn 34, Issue 8, 2014, Pages 771-793

  Touchette, Daniel R ^a   Doloresco, Fred ^b   Suda, Katie J ^c   Perez, Alexandra ^d   Turner, Stuart ^e   Jalundhwala, Yash ^a   Tangonan, Maria C ^a   Hoffman, James M ^c  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^d NOVA SOUTHEASTERN UNIVERSITY   (United States)

^e RUTGERS UNIVERSITY   (United States)

Author keywords

benefit cost; clinical pharmacy services; cost; cost effectiveness; cost utility; economic evaluation; outcomes

Indexed keywords

ANTITHROMBOCYTIC AGENT;

ANGINA PECTORIS; ASTHMA; CERTIFICATION; CLINICAL PHARMACY; COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; COST MINIMIZATION ANALYSIS; COST UTILITY ANALYSIS; DECUBITUS; DIABETES MELLITUS; DRUG COST; DRUG MONITORING; HEALTH CARE FACILITY; HEART FAILURE; HUMAN; IMMUNIZATION; INTERNATIONAL COOPERATION; KNEE PAIN; LEG ULCER; MEDICAL EDUCATION; PATIENT EDUCATION; PHARMACIST; PHARMACOECONOMICS; PROFESSIONAL PRACTICE; REVIEW; SYSTEMATIC REVIEW; THROMBOSIS; WELLBEING; WORK EXPERIENCE; ECONOMICS; HOSPITAL PHARMACY; ORGANIZATION AND MANAGEMENT; PATIENT CARE; PROFESSIONAL STANDARD;

COST-BENEFIT ANALYSIS; HUMANS; PATIENT CARE; PHARMACISTS; PHARMACY SERVICE, HOSPITAL; PROFESSIONAL ROLE;

EID: 84905912988     PISSN: 02770008     EISSN: 18759114     Source Type: Journal    
DOI: 10.1002/phar.1414     Document Type: Review

References (45)

1. Chisholm-Burns MA, Graff Zivin JS, Lee JK, et al. Economic effects of pharmacists on health outcomes in the United States: a systematic review. Am J Health Syst Pharm 2010; 67: 1624-34.
2. Perez A, Doloresco F, Hoffman JM, et al. ACCP: economic evaluations of clinical pharmacy services: 2001-2005. Pharmacotherapy 2009; 29: 128.
3. Schumock GT, Butler MG, Meek PD, Vermeulen LC, Arondekar BV, Bauman JL,. Evidence of the economic benefit of clinical pharmacy services: 1996-2000. Pharmacotherapy 2003; 23: 113-32.
4. Schumock GT, Meek PD, Ploetz PA, Vermeulen LC,. Economic evaluations of clinical pharmacy services-1988-1995. The Publications Committee of the American College of Clinical Pharmacy. Pharmacotherapy 1996; 16: 1188-208.
5. Burke JM, Miller WA, Spencer AP, et al. Clinical pharmacist competencies. Pharmacotherapy 2008; 28: 806-15.
6. The definition of clinical pharmacy. Pharmacotherapy 2008; 28: 816-7.
7. Ramalho de Oliveira D, Brummel AR, Miller DB,. Medication therapy management: 10 years of experience in a large integrated health care system. J Manag Care Pharm 2010; 16: 185-95.
8. Anonymous. Public law 108-173. The Medicare prescription drug, improvement, and modernization act of 2003. HR1. December 8, 2003. Available from http://www.cms.gov/CCIP/downloads/section-721.pdf. Accessed June 12, 2010.
9. The Publications Committee of the American Hospital Association. Patient-centered medical home: AHA research synthesis report. 2010: 2-21. Available from http://www.aha.org/research/cor/content/patient-centered-medical- home.pdf. Accessed July 12, 2013.
10. Rucker NL,. Medicare Part D's medication therapy management shifting from neutral to drive. AARP. 2012: 1-12. Available from http://www.aarp.org/content/ dam/aarp/research/public-policy-institute/health/medicare-part-d-shifting-from- neutral-to-drive-insight-AARP-ppi-health.pdf. Accessed June 27, 2012.
11. Willett MS, Bertch KE, Rich DS, Ereshefsky L,. Prospectus on the economic value of clinical pharmacy services. A position statement of the American College of Clinical Pharmacy. Pharmacotherapy 1989; 9: 45-56.
12. Schumock GT, Pickard AS,. Comparative effectiveness research: relevance and applications to pharmacy. Am J Health Syst Pharm 2009; 66: 1278-86.
13. Chisholm-Burns MA, Kim Lee J, Spivey CA, et al. US pharmacists' effect as team members on patient care: systematic review and meta-analyses. Med Care 2010; 48: 923-33.
14. Buscemi N, Hartling L, Vandermeer B, Tjosvold L, Klassen TP,. Single data extraction generated more errors than double data extraction in systematic reviews. J Clin Epidemiol 2006; 59: 697-703.
15. Drummond MF,. Methods for the economic evaluation of health care programmes, 3rd ed. New York, NY: Oxford University Press; 2005.
16. Ofman JJ, Sullivan SD, Neumann PJ, et al. Examining the value and quality of health economic analyses: implications of utilizing the QHES. J Manag Care Pharm 2003; 9: 53-61.
17. Scott A, Tinelli M, Bond C,. Costs of a community pharmacist-led medicines management service for patients with coronary heart disease in England: healthcare system and patient perspectives. Pharmacoeconomics 2007; 25: 397-411.
18. The Community Pharmacy Medicines Management Project Evaluation Team. The MEDMAN study: a randomized controlled trial of community pharmacy-led medicines management for patients with coronary heart disease. Fam Pract 2007; 24: 189-200.
19. Lam AY, Chung Y,. Establishing an on-site influenza vaccination service in an assisted-living facility. J Am Pharm Assoc (2003) 2008; 48: 758-63.
20. American Pharmacists Association; National Association of Chain Drug Stores Foundation. Medication therapy management in community pharmacy practice: core elements of an MTM service (version 1.0). J Am Pharm Assoc (2003) 2005; 45: 573-9.
21. Murray MD, Young J, Hoke S, et al. Pharmacist intervention to improve medication adherence in heart failure: a randomized trial. Ann Intern Med 2007; 146: 714-25.
22. Lopez Cabezas C, Falces Salvador C, Cubi Quadrada D, et al. Randomized clinical trial of a postdischarge pharmaceutical care program vs regular follow-up in patients with heart failure. Farm Hosp 2006; 30: 328-42.
23. Bond CM, Fish A, Porteous TH, Reid JP, Scott A, Antonazzo E,. A randomised controlled trial of the effects of note-based medication review by community pharmacists on prescribing of cardiovascular drugs in general practice. Int J Pharm Pract 2007; 15: 39-46.
24. Hay EM, Foster NE, Thomas E, et al. Effectiveness of community physiotherapy and enhanced pharmacy review for knee pain in people aged over 55 presenting to primary care: pragmatic randomised trial. BMJ 2006; 333: 995.
25. Phelan M, Blenkinsopp A, Foster NE, Thomas E, Hay EM,. Pharmacist-led medication review for knee pain in older adults: content, process and outcomes. Int J Pharm Pract 2008; 16: 347-88.
26. Vu T, Harris A, Duncan G, Sussman G,. Cost-effectiveness of multidisciplinary wound care in nursing homes: a pseudo-randomized pragmatic cluster trial. Fam Pract 2007; 24: 372-9.
27. Bunting BA, Smith BH, Sutherland SE,. The Asheville Project: clinical and economic outcomes of a community-based long-term medication therapy management program for hypertension and dyslipidemia. J Am Pharm Assoc (2003) 2008; 48: 23-31.
28. Bunting BA, Cranor CW,. The Asheville Project: long-term clinical, humanistic, and economic outcomes of a community-based medication therapy management program for asthma. J Am Pharm Assoc (2003) 2006; 46: 133-47.
29. Fera T, Bluml BM, Ellis WM,. Diabetes Ten City Challenge: final economic and clinical results. J Am Pharm Assoc (2003) 2009; 49: 383-91.
30. Swoboda S, Lichtenstern C, Ober MC, et al. Implementation of practice guidelines for antifungal therapy in a surgical intensive care unit and its impact on use and costs. Chemotherapy 2009; 55: 418-24.
31. Weant KA, Armitstead JA, Ladha AM, Sasaki-Adams D, Hadar EJ, Ewend MG,. Cost effectiveness of a clinical pharmacist on a neurosurgical team. Neurosurgery 2009; 65: 946-50; discussion 50-1.
32. Altavela JL, Jones MK, Ritter M,. A prospective trial of a clinical pharmacy intervention in a primary care practice in a capitated payment system. J Manag Care Pharm 2008; 14: 831-43.
33. Pacini M, Smith RD, Wilson EC, Holland R,. Home-based medication review in older people: is it cost effective? Pharmacoeconomics 2007; 25: 171-80.
34. Lampert ML, Kraehenbuehl S, Hug BL,. Drug-related problems: evaluation of a classification system in the daily practice of a Swiss University Hospital. Pharm World Sci 2008; 30: 768-76.
35. RESPECT Trial Team. Cost-effectiveness of shared pharmaceutical care for older patients: RESPECT trial findings. Br J Gen Pract 2010; 60: e20-7.
36. Blewett LA, Johnson K, McCarthy T, Lackner T, Brandt B,. Improving geriatric transitional care through inter-professional care teams. J Eval Clin Pract 2010; 16: 57-63.
37. De Giorgi I, Fonzo-Christe C, Cingria L, et al. Risk and pharmacoeconomic analyses of the injectable medication process in the paediatric and neonatal intensive care units. Int J Qual Health Care 2010; 22: 170-8.
38. Lalonde L, Martineau J, Blais N, et al. Is long-term pharmacist-managed anticoagulation service efficient? A pragmatic randomized controlled trial. Am Heart J 2008; 156: 148-54.
39. Buck TC, Brandstrup L, Brandslund I, Kampmann JP,. The effects of introducing a clinical pharmacist on orthopaedic wards in Denmark. Pharm World Sci 2007; 29: 12-8.
40. Malfair Taylor SC, de Lemos ML, Jang D, et al. Impact on patient satisfaction with a structured counselling approach on natural health products. J Oncol Pharm Pract 2008; 14: 37-43.
41. Moffett BS, Mott AR, Nelson DP, Gurwitch KD,. Medication dosing and renal insufficiency in a pediatric cardiac intensive care unit: impact of pharmacist consultation. Pediatr Cardiol 2008; 29: 744-8.
42. Guillaume L, Cooper R, Avery A, et al. Supplementary prescribing by community and primary care pharmacists: an analysis of PACT data, 2004-2006. J Clin Pharm Ther 2008; 33: 11-6.
43. Karnon J, McIntosh A, Dean J, et al. Modelling the expected net benefits of interventions to reduce the burden of medication errors. J Health Serv Res Policy 2008; 13: 85-91.
44. Anonymous. Public law 111-148. Compilation of patient protection and affordable care act. May 1, 2010. Available from http://housedocs.house.gov/ energycommerce/ppacacon.pdf. Accessed July 12, 2013.
45. Sibbald B, McDonald R, Roland M,. Shifting care from hospitals to the community: a review of the evidence on quality and efficiency. J Health Serv Res Policy 2007; 12: 110-7.